These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 406336

  • 1. Chemotherapy of experimental streptococcal endocarditis. VI. Prevention of enterococcal endocarditis.
    Durack DT, Starkebaum MK, Petersdorf RG.
    J Lab Clin Med; 1977 Jul; 90(1):171-9. PubMed ID: 406336
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J, Onrubia PL, Gómez MT, Gomis X, Ramírez JL, Len O, Rodríguez D, Crespo M, Ruíz I, Pahissa A.
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [Abstract] [Full Text] [Related]

  • 4. Endocarditis due to streptomycin-susceptible Enterococcus faecalis with high-level gentamicin resistance.
    Spiegel CA, Huycke M.
    Arch Intern Med; 1989 Aug; 149(8):1873-5. PubMed ID: 2504123
    [Abstract] [Full Text] [Related]

  • 5. Enterococcal endocarditis.
    Wilkowske CJ.
    Mayo Clin Proc; 1982 Feb; 57(2):101-5. PubMed ID: 6798333
    [Abstract] [Full Text] [Related]

  • 6. Synergistic treatment of enterococcal endocarditis: in vitro and in vivo studies.
    Serra P, Brandimarte C, Martino P, Carlone S, Giunchi G.
    Arch Intern Med; 1977 Nov; 137(11):1562-7. PubMed ID: 921443
    [Abstract] [Full Text] [Related]

  • 7. Antibiotic prophylaxis against streptomycin-resistant and -susceptible Streptococcus faecalis endocarditis in rabbits.
    Guze PA, Kalmanson GM, Freedman LR, Ishida K, Guze LB.
    Antimicrob Agents Chemother; 1983 Oct; 24(4):514-7. PubMed ID: 6418063
    [Abstract] [Full Text] [Related]

  • 8. [Enterococcal endocarditis, a model of therapeutic difficulty].
    Fernández Guerrero ML, Núñez García A.
    Rev Clin Esp; 1995 Oct; 195 Suppl 4():41-5. PubMed ID: 9441316
    [No Abstract] [Full Text] [Related]

  • 9. Antibiotic synergism in enterococcal endocarditis.
    Carrizosa J, Kaye D.
    J Lab Clin Med; 1976 Jul; 88(1):132-41. PubMed ID: 819602
    [Abstract] [Full Text] [Related]

  • 10. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
    Pişkin N, Akduman D, Aydemir H, Celebi G, Oztoprak N, Aktaş E.
    Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
    [Abstract] [Full Text] [Related]

  • 11. Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.
    Pelletier LL, Durack DT, Petersdorf RG.
    J Clin Invest; 1975 Aug; 56(2):319-30. PubMed ID: 1150874
    [Abstract] [Full Text] [Related]

  • 12. A case of vancomycin-resistant enterococcal endocarditis.
    Brink AJ, van den Ende J, Routier RJ, Devenish L.
    S Afr Med J; 2000 Nov; 90(11):1113-5. PubMed ID: 11196031
    [No Abstract] [Full Text] [Related]

  • 13. Endocarditis after ciprofloxacin therapy for enterococcal pyelonephritis with bacteremia.
    McDonald GR.
    J Tenn Med Assoc; 1993 Dec; 86(12):527-8. PubMed ID: 8295423
    [No Abstract] [Full Text] [Related]

  • 14. Gentamicin-resistant enterococcal endocarditis: the need for routine screening for high-level resistance to aminoglycosides.
    Libertin CR, McKinley KM.
    South Med J; 1990 Apr; 83(4):458-60. PubMed ID: 2108503
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of enterococcal septicemia and endocarditis].
    Bengtsson E, Svanbom M, Tunevall G.
    Lakartidningen; 1971 Mar 03; 68(10):1087-92. PubMed ID: 5573786
    [No Abstract] [Full Text] [Related]

  • 16. Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.
    Bayer AS, Tu J.
    Antimicrob Agents Chemother; 1990 Jun 03; 34(6):1068-74. PubMed ID: 2118323
    [Abstract] [Full Text] [Related]

  • 17. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.
    Miro JM, Cervera C, Garcia-de-la-Maria C, Del Rio A, Armero Y, Mestres CA, Grau JM, Marco F, Moreno A.
    Scand J Infect Dis; 2008 Jun 03; 40(11-12):968-72. PubMed ID: 18767002
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Prevention of bacterial endocarditis].
    Jeljaszewicz J, Hryniewicz W.
    Kardiol Pol; 1978 Jun 03; 21(5):475-8. PubMed ID: 101706
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.